Compare WST & LI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WST | LI |
|---|---|---|
| Founded | 1923 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6B | 16.8B |
| IPO Year | 2004 | N/A |
| Metric | WST | LI |
|---|---|---|
| Price | $250.46 | $17.29 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 9 |
| Target Price | ★ $319.43 | $20.46 |
| AVG Volume (30 Days) | 918.6K | ★ 2.8M |
| Earning Date | 05-15-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.35% | N/A |
| EPS Growth | ★ 1.49 | N/A |
| EPS | ★ 6.79 | N/A |
| Revenue | ★ $2,886,900,000.00 | N/A |
| Revenue This Year | $6.73 | N/A |
| Revenue Next Year | $6.07 | $20.77 |
| P/E Ratio | $36.94 | ★ $29.50 |
| Revenue Growth | ★ 1.95 | N/A |
| 52 Week Low | $187.43 | $15.71 |
| 52 Week High | $322.34 | $32.03 |
| Indicator | WST | LI |
|---|---|---|
| Relative Strength Index (RSI) | 51.94 | 43.24 |
| Support Level | $244.30 | $16.15 |
| Resistance Level | $261.98 | $17.65 |
| Average True Range (ATR) | 8.22 | 0.38 |
| MACD | 1.68 | -0.19 |
| Stochastic Oscillator | 71.47 | 27.39 |
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 500,000 NEVs in 2024, accounting for about 4% of China's passenger new energy vehicle market. Beyond Li One, the company expands its product line, including both BEVs and PHEVs, to target a broader consumer base.